Spectrum Pharmaceutecals Inc (SPPI)

[Chickadee]

Load up now before Friday, Sept 4th... before our 3 day Labor Day weekend.

Two crucial FDA Decision Dates:

September 7: Zevalin
October 8: Fusilev

Spectrum Pharma: Expect a Positive FDA Decision

This Labor Day, September 7, Spectrum Pharmaceuticals (NASDAQ:SPPI) expects an FDA decision for their non-Hodgkin’s lymphoma (NHL) radio-immunotherapeutic (RIT), Zevalin.

Since institutional investors and hedge funds have been slow to catch on, SPPI still remains a hidden gem and an excellent investment opportunity.

· With a current price of $6.32 and a market cap of a mere $263 million, I anticipate shares of SPPI will likely see a dramatic rise in the coming weeks and months.

· Over the next 6 to 12 months, my price target for SPPI ranges between $23.80 and $26.67 with a market cap from $1.0 to $1.12 billion.

· If Zevalin sales continue to improve, then I anticipate that SPPI could likely be acquired within 12 to 18 months.

http://biomedreports.com/articles/most-popular/6482-spectrum-pharma-the-labor-day-catalyst-.html

http://seekingalpha.com/article/157792-spectrum-pharma-expect-a-positive-fda-decision